Pharmaceutical composition or health-care functional food containing novel hybrid mushroom powder as active ingredient for preventing and treating obesity

The present invention provides a pharmaceutical composition for treating obesity and fatty liver diseases due to high fat diet, which contains, as an active ingredient, a powder of sporocarp or hypha of hybrid mushroom strain GBN2WP0970, which powder has no side effects and has an excellent effect of inhibiting neutral fat absorption. 本发明提供了一种用于治疗因高脂饮食所致的肥胖症和脂肪肝病的药物组合物，其含有作为活性成分的杂交蘑菇菌株GBN2WP0970的子实体或菌丝的粉末，该粉末无副作用且具有优异的抑制中性脂肪吸收的作用。